510(k) K972884

ACCURUN 146 CMV IGM POSITIVE CONTROL by Boston Biomedica, Inc. — Product Code LKQ

K972884 is an FDA 510(k) premarket notification submitted by Boston Biomedica, Inc. for the device "ACCURUN 146 CMV IGM POSITIVE CONTROL". The FDA issued a decision of Substantially Equivalent on August 22, 1997. The device falls under product code LKQ (Antibody Igm,If, Cytomegalovirus Virus), a Class II device regulated under 21 CFR 866.3175. Boston Biomedica, Inc. has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
August 22, 1997
Date Received
August 5, 1997
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Antibody Igm,If, Cytomegalovirus Virus
Device Class
Class II
Regulation Number
866.3175
Review Panel
MI
Submission Type